Early-stage FY 2026 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards
Outline
| Status of Grants/Funding Opportunities | Grants/Funding Opportunities |
|---|---|
| R&D phase | Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Research |
| Key Fields | Basic Research for Medical Innovation, Infectious disease |
| Submission Deadline | 08/21/26 Fri Full Proposal Submission via e-Rad; Thursday, August 20, 2026 (23:59) U.S. Eastem Time (EDT) (UTC-4) Friday, August 21, 2026 (12:59) Japan Standard Time (JST) (UTC＋9) * All proposal documents should be submitted via e-Rad by the Japan-based PI on behalf of the collaborative team to AMED. |
| Contact |
|
Public offering content
Japan Agency for Medical Research and Development (AMED), in collaboration with U.S. National Institute of Allergy and Infectious Diseases (NIAID), is pleased to announce the joint request for proposals on "Infectious Diseases and Immunology Research: US-Japan Cooperative Medical Sciences Program Collaborative Awards, 2026".
Awardees are expected to present their achievements at International Conference on Emerging Infectious Diseases in the Pacific Rim after 2027.
| Research areas | Project size (Direct costs + Indirect costs) |
Research period | Number of projects to be awarded |
|---|---|---|---|
|
60,000 USD* | Maximum duration: 2 years (January 1, 2027 to December 31, 2028) |
4-6 projects (expected) |
*The maximum total award is up to $60,000 USD disbursed over two years. Sub-team budget allocation percentages must total 100%.
For details, please refer to the complete Request for Proposals.
Program summary
Overview of US-Japan Cooperative Medical Sciences Program
The US-Japan Cooperative Medical Sciences Program (USJCMSP), one of the oldest bilateral programs in the history of, was established in 1965 (under a U.S. Presidential-Japan Prime Ministerial level agreement) to strengthen Japanese research capacity and address issues of public health importance in the Asia Pacific region. The program continues to maintain its value as a unique tool to foster U.S., Japan, and Asia Pacific Region research collaboration.
For more:
Eligibility
- Collaborative research teams consisting of investigators from (1) Japan and the U.S. , or (2) Japan, the U.S., and other Asia Pacific countries, are eligible to apply.
- Each application must include an early-stage investigator as a PI in both the Japan-based and U.S.-based sub-teams. For the Japan-based sub-team only, a female investigator may alternatively fulfill this requirement.
For complete eligibility requirements, please refer to the Request for Proposals.
Solicitation Period
Full Proposal Submission via e-Rad;
Thursday, August 20, 2026 (23:59) U.S. Eastem Time (EDT) (UTC-4)
Friday, August 21, 2026 (12:59) Japan Standard Time (JST) (UTC＋9)
* All proposal documents should be submitted via e-Rad by the Japan-based PI on behalf of the collaborative team to AMED.
How to Apply
To apply, please follow the information on the Request for Proposals and the AMED Supplemental Application Guideline for Japanese Sub-teams (in Japanese).
Reference
06/01/26
Last updated 06/01/26